1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow C. Diff: new trials by email Literature Review of C. Diff trials Research Report on C. Diff
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection CP101 - Clostridium Difficile Infection, Recurrent Clostridium Difficile Infection | Phase 2 | Completed | Finch Research and Development LLC. | 132 | 2018-05-01 | 2022-08-30 |
Clostridium Infections (1) · Diabetes Insipidus, Neurogenic (1)
Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Diabetes Insipidus (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Gram-Positive Bacterial Infections (1) · Infections (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Pituitary Diseases (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Finch Research and Development LLC. (1)
Canada (1) · United States (1)